Zivo Bioscience Inc (ZIVO) Prix

Zivo Bioscience, Inc. engages in the study, development, and commercialization of natural nutritional compounds and bioactive molecules. The company is headquartered in Troy, Michigan and currently employs 7 full-time employees. The company went IPO on 2000-10-06. The firm operates in the biotech and agtech sectors, with an intellectual property portfolio comprised of algal and bacterial strains, biologically active molecules and complexes, production and cultivation techniques and patented or patent-pending inventions for applications in human and animal health. Its product candidates are at different stages of development for different applications. The company is developing a product candidate targeting poultry gut health and Avian Influenza, Bovine Mastitis, Canine Joint Health, Human Immune Modulation, Algal biomass for human consumption, and Biomass for supporting skin health/anti-aging. The company is focused on licensing and selling natural bioactive ingredients derived from the proprietary algae cultures to animal, human and dietary supplement, and medical food manufacturers. The company sells its vegan protein powder, which is a dried green algae nutritional product, under the brand name ZIVOLife.